Intratumoral PEG-interleukin-2 therapy in patients with loco…
Intratumoral PEG-interleukin-2 therapy in patients with locoregionally recurrent head and neck squamous-cell carcinoma
Article, Chapter
Full text availability for this item
Collection:
Elsevier ScienceDirect Journals
Coverage:
- 1990~present
Collection:
PubMed Central
Coverage:
- 1990~12 months ago